
Brooklyn Hospital Center
Brooklyn, New York

Family Support Center
Brooklyn, New York

Legacy Behavioral Health Services
Brooklyn, New York

Legacy Recovery Center
Brooklyn, New York
No centers match
Try a different search term
4 SAMHSA-listed treatment centers in Brooklyn, New York. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.

Brooklyn, New York

Brooklyn, New York

Brooklyn, New York

Brooklyn, New York
Try a different search term
Brooklyn, New York has 4 SAMHSA-verified addiction treatment centers offering a range of evidence-based programs. New York City and surrounding areas face a persistent opioid crisis, with fentanyl now present in most street drugs.
Available programs in Brooklyn include 1 residential/inpatient rehab program, 2 outpatient programs, 1 dual diagnosis (co-occurring mental health) program, and 2 medical detox facilities. All listed facilities are sourced directly from the federal SAMHSA National Registry of Substance Abuse Treatment Services.
Most treatment centers in Brooklyn accept Medicaid, Medicare, and major private insurance plans including Aetna, Cigna, BlueCross BlueShield, and UnitedHealthcare. Under the Affordable Care Act (ACA) and the Mental Health Parity Act, insurance providers are required to cover substance use disorder treatment at the same level as other medical conditions. Call (319) 271-2077 for a free insurance verification — no obligation, completely confidential.
When selecting from the 4 treatment options in Brooklyn, consider: the type and severity of the substance use disorder, whether co-occurring mental health conditions require dual diagnosis treatment, your insurance coverage and financial situation, the distance from home and your support network, and the facility's accreditation and evidence-based approach. Our helpline is available 24/7 at (319) 271-2077 to help match you with the right program — free and confidential.
Free, confidential assistance matching you with the right program in Brooklyn.
Treatment centers in Brooklyn accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Residential treatment in Brooklyn programs typically lasts 28-90 days, with length-of-stay determined by clinical response rather than insurance authorization alone. Short residential stays (28-30 days) suit patients with milder presentations, stable home environments, and strong outpatient follow-through capacity. Extended residential (60-90+ days) typically serves patients with severe addiction histories, prior treatment episodes, significant trauma histories, or unstable home environments that would compromise recovery without extended separation.
Treatment programs serving Brooklyn, New York differ along several axes worth understanding before contact: intensity (outpatient through residential), specialty (population fit — adolescents, women-only, men-only, professionals, LGBTQ+, veterans, dual-diagnosis), modality emphasis (12-step versus secular versus evidence-based behavioral therapy versus medication-assisted treatment), and payor mix (commercial insurance, Medicaid, self-pay). Matching patient to program along these axes substantially improves engagement and outcome metrics compared to placement based on convenience or availability alone.
Pregnant women in Brooklyn with active substance use should not stop opioid use abruptly if dependent — withdrawal during pregnancy carries fetal risk including preterm labor and stillbirth. Evidence-based care is buprenorphine or methadone maintenance (NOT detox), continued through pregnancy and postpartum. New York maternal-fetal medicine specialists, OB-GYNs trained in addiction medicine, and SAMHSA's Center of Excellence for Pregnant and Postpartum Women with Opioid Use Disorder provide specialized care pathways for this population.
Aftercare for Brooklyn patients begins planning during the initial treatment episode, not at discharge. Standard components include: a named outpatient provider with a scheduled first appointment within 7 days, medication continuation plans (MAT, psychiatric medications, medical comorbidities), a sober-housing recommendation if returning home presents relapse risk, introduction to mutual-support communities matched to patient preference (AA, NA, SMART Recovery, Refuge Recovery, LifeRing), and a relapse-prevention plan with named triggers, named coping skills, and named support contacts.
Family involvement in Brooklyn program admission typically begins with the admissions call itself — many patients seeking treatment have a family member or partner initiating the contact. Most facilities allow family conversations during the admission process (subject to 42 CFR Part 2 confidentiality), schedule family education or therapy sessions early in treatment, and explicitly involve family in discharge planning. Family-system engagement correlates with better treatment outcomes across the literature.
Cost expectations for Brooklyn residential addiction treatment span a wide range: standard 30-day residential at facilities accepting most commercial insurance often runs $10,000-$30,000 in pre-insurance billing; premium or specialty programs (luxury, executive, specialized clinical focus) can run $30,000-$70,000+. With in-network commercial insurance, patient out-of-pocket typically lands at the plan's annual out-of-pocket maximum, often $7,000-$10,000 for an individual. Medicaid-covered treatment generally has no direct patient cost beyond modest copays where applicable.
Depression co-occurs with substance use disorders at high rates and is often a treatment-complicating factor for Brooklyn patients. Substance use can mask depressive symptoms, withdrawal can produce transient depression, and protracted post-acute withdrawal syndrome (PAWS) can extend depressive episodes well past acute detox. Quality Brooklyn programs distinguish primary depression (preceded substance use) from substance-induced depression (would resolve with sustained abstinence) and treat accordingly — psychiatric medication management for the former, watchful waiting plus behavioral activation for the latter.